Sun Pharmaceutical Industries, Inc.

Phase 3 Estimated

Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%

Actinic Keratosis

Countdown

208days

Phase 3 readout · ~ Jan 31, 2027 estimated

What's at stake Phase 3 trial results for Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20% in Actinic Keratosis are due ~ Jan 31, 2027. A clean hit validates the program; a miss can gap the stock down hard.

Primary source · ClinicalTrials.gov verified 15h ago

“CT.gov NCT07144852: Phase 3 trial, sponsor Sun Pharmaceutical Industries, Inc., drug Reformulated Levulan Kerastick containing aminolevulinic acid hydrochloride (ALA HCl), 20%. Primary completion date 2027-01 (estimated).”

Add to calendar Post on X Reddit

Provenance